12 Information Technology Stocks Moving In Monday’s Intraday Session
Gainers Cantaloupe (NASDAQ:CTLP) stock rose 13.2% to $6.01 during Monday’s regular session. Trading volume for Cantaloupe’s stock is…
Analyst Ratings for Cognex
Within the last quarter, Cognex (NASDAQ:CGNX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Needham Maintains Buy on Cognex, Raises Price Target to $58
Needham analyst James Ricchiuti maintains Cognex (NASDAQ:CGNX) with a Buy and raises the price target from $54 to $58.
Moderna, Cognex, Stem And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
XP Inc (NASDAQ: XP) shares tumbled 13.1% to $13.82 in pre-market trading after the company reported a drop in Q4 net revenue.
12 Information Technology Stocks Moving In Thursday’s After-Market Session
Gainers HubSpot (NYSE:HUBS) shares moved upwards by 12.9% to $408.65 during Thursday’s after-market session. Today’s trading volume for…
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell
• RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022.
• Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
Cognex, Altria Group, Kinder Morgan And This Energy Giant: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust named Cognex Corporation (NASDAQ: CGNX) as her final trade, saying
Benzinga’s Top Ratings Upgrades, Downgrades For January 17, 2023
Upgrades For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform.…
Benzinga Pro’s Top 5 Stocks To Watch For Tuesday, January 17, 2023: MSFT, FDX, IBKR, MANU, BTCM
Microsoft (MSFT) - Shares were downgraded to Sell by analysts at Guggenheim Tuesday morning. The downgrade came ahead of Microsoft's Q2 earnings report on Tuesday of next
Morgan Stanley Downgrades Cognex to Underweight, Lowers Price Target to $40
Morgan Stanley analyst Joshua Pokrzywinski downgrades Cognex (NASDAQ:CGNX) from Equal-Weight to Underweight and lowers the price target from $41 to $40.